Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

One Health approach strengthened

New UK strategy to tackle antimicrobial resistance

A UK Five Year Antimicrobial Resistance Strategy has been published, calling for a One Health approach in both human and animal medicine.

It follows a report, which dates back to March, put together by the UK's chief medical officer to highlight the scale of threat from antimicrobial resistance.

Taking effect from 2013 to 2018, the strategy has been jointly published by the Department for Environment, Food and Rural Affairs (Defra), the Department of Health, Scottish Government, Welsh Government and the Northern Ireland Executive.

It outlines the following seven key areas for action over the next five years:

1. Improving infection prevention and control practices
2. Optimising prescribing practice
3. Improving education, training and public engagement
4. Developing new drugs, treatments and diagnostics
5. Better access to and use of surveillance
6. Better identification and prioritisation or antimicrobial resistance research needs
7. Strengthened international collaboration

The strategy also details specific duties under each sector and acknowledges action already taken within the veterinary profession, such as the Royal College of Veterinary Surgeons' guidelines and posters of responsible antimicrobial use.

It has been made clear in the report that scientific evidence suggests antibiotic use in humans, rather that animals, is the primary cause of clinical antimicrobial resistance issues in human medicine.

However, its use in animals is also a contributory factor that must be addressed.

Peter Jones, president of the British Veterinary Association (BVA), said: "Antimicrobial resistance is indeed one of the most significant threats to animal and human health and we fully support the aims of the UK strategy.

"We fully recognise the need to tackle resistance in animals… the One Health approach of medical and veterinary professionals working together will be crucial to the success of the strategy."

Related News
Ants offer lead on new antibiotics
Step forward in fighting superbugs

 

Become a member or log in to add this story to your CPD history

Annual submission deadline small pet animal exemptions

News Story 1
 Companies marketing medicines for small pets exempt from authorisation must submit their annual return to the Veterinary Medicines Directorate (VMD) by 30 November 2026.

Submitting this annual return ensures continued compliance with regulatory requirements for products marketed without a full Marketing Authorisation. The exemption specifically applies to products intended for animals, cage birds, terrarium animals, small rodents, ferrets and rabbits.

For further details and submission guidelines, visit the gov.uk website.  

Click here for more...
News Shorts
BVA urges 'continued vigilance' over bluetongue

The British Veterinary Association (BVA) has urged vigilance following a concerning rise in Bluetongue (BTV) cases in sheep and cattle.

In a recent statement, the BVA noted that members are reporting more severe clinical signs and higher mortality rates than in previous years.

'We know that farm vets are working hard to support farmers and animals affected by this outbreak, during what is an extremely difficult time for all involved,' they stated. 'Continued vigilance to identify disease early is vital and vaccination remains the best way of protecting animals from this disease.'